Etiologic Treatment With Benznidazole in Adult Patients With Chronic Chagas Disease. A Randomized Clinical Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

910

Participants

Timeline

Start Date

March 31, 1999

Primary Completion Date

December 31, 2012

Study Completion Date

April 30, 2013

Conditions
Chagas Disease
Interventions
DRUG

Benznidazole

Benznidazole at a dose 5 mg/Kg/day until 60 days have been completed or development of non-acceptable toxicity-

DRUG

Placebo

Placebo at a dose 5 m/Kg/day until 60 days

Trial Locations (1)

1063

Instituto Nacional de Parasitología Dr Mario Fatala Chaben, Ciudad Autónoma de Buenos Aires

All Listed Sponsors
collaborator

National Council of Scientific and Technical Research, Argentina

OTHER_GOV

collaborator

Pan American Health Organization

OTHER

collaborator

Becas Carrillo Oñativia, Ministerio de Salud, Argentina

UNKNOWN

collaborator

Drugs for Neglected Diseases

OTHER

lead

Instituto Nacional de Parasitologia Dr. Mario Fatala Chaben

OTHER_GOV

NCT02386358 - Etiologic Treatment With Benznidazole in Adult Patients With Chronic Chagas Disease. A Randomized Clinical Trial | Biotech Hunter | Biotech Hunter